Fundacao Champalimaud
Clinical trials sponsored by Fundacao Champalimaud, explained in plain language.
-
Can exercise tweak tumor biology? new trial tests aerobic vs. resistance training in breast cancer
Disease control CompletedThis trial investigates whether structured exercise—either aerobic cycling or resistance training—can improve health-related biomarkers in women with breast cancer undergoing neoadjuvant therapy (chemotherapy or endocrine therapy before surgery). The main focus is on changes in K…
Phase: NA • Sponsor: Fundacao Champalimaud • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New radiation approach shows promise for prostate cancer control
Disease control CompletedThis study tested a new way to give radiation therapy for prostate cancer. It used very precise, high-dose radiation over just five days. The goal was to control the cancer while reducing side effects on the bladder and bowel. 444 men with localized prostate cancer took part, and…
Phase: NA • Sponsor: Fundacao Champalimaud • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
One-Time radiation blast shows promise for containing limited metastatic cancer
Disease control CompletedThis study tested whether a single, high dose of targeted radiation can control cancer that has spread to just a few spots (1-5 tumors). 150 adults with limited metastatic cancer received this treatment to see if it could delay further spread and improve survival. The goal is to …
Phase: NA • Sponsor: Fundacao Champalimaud • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC